US 11964985
Anti-cancer compounds targeting Ral GTPases and methods of using the same
granted A61KA61K31/351A61K31/4162
Quick answer
US patent 11964985 (Anti-cancer compounds targeting Ral GTPases and methods of using the same) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/351, A61K31/4162, A61K31/437, A61K31/505